| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
ABCA12
|
ATP-binding cassette, sub-family A (ABC1), member 12
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ACAN
|
aggrecan
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACTN4
|
actinin, alpha 4
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRM1
|
adhesion regulating molecule 1
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALDH1L1
|
aldehyde dehydrogenase 1 family, member L1
|
|
AMH
|
anti-Mullerian hormone
|
|
AMOTL1
|
angiomotin like 1
|
|
ANO10
|
anoctamin 10
|
|
ANXA1
|
annexin A1
|
|
AP3B1
|
adaptor-related protein complex 3, beta 1 subunit
|
|
APC
|
adenomatous polyposis coli
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
|
|
APOE
|
apolipoprotein E
|
|
AR
|
androgen receptor
|
|
ARL13B
|
ADP-ribosylation factor-like 13B
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATRIP
|
ATR interacting protein
|
|
AURKA
|
aurora kinase A
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BMP1
|
bone morphogenetic protein 1
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRD7
|
bromodomain containing 7
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QB
|
complement component 1, q subcomponent, B chain
|
|
C1QC
|
complement component 1, q subcomponent, C chain
|
|
CA2
|
carbonic anhydrase II
|
|
CACNG2
|
calcium channel, voltage-dependent, gamma subunit 2
|
|
CALHM1
|
calcium homeostasis modulator 1
|
|
CALR
|
calreticulin
|
|
CAPN10
|
calpain 10
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCRL2
|
chemokine (C-C motif) receptor-like 2
|
|
CD14
|
CD14 molecule
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD24
|
CD24 molecule
|
|
CD274
|
CD274 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD69
|
CD69 molecule
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CENPA
|
centromere protein A
|
|
CEP164
|
centrosomal protein 164kDa
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHGA
|
chromogranin A
|
|
CHGB
|
chromogranin B
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLDN1
|
claudin 1
|
|
CLDN17
|
claudin 17
|
|
CLDN22
|
claudin 22
|
|
CLDN23
|
claudin 23
|
|
CLDN24
|
claudin 24
|
|
CLDN3
|
claudin 3
|
|
CLDN4
|
claudin 4
|
|
CLDN6
|
claudin 6
|
|
CLDN8
|
claudin 8
|
|
CLDN9
|
claudin 9
|
|
CNOT1
|
CCR4-NOT transcription complex, subunit 1
|
|
CNOT2
|
CCR4-NOT transcription complex, subunit 2
|
|
CNOT3
|
CCR4-NOT transcription complex, subunit 3
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COCH
|
cochlin
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL5A1
|
collagen, type V, alpha 1
|
|
COMMD1
|
copper metabolism (Murr1) domain containing 1
|
|
COPS5
|
COP9 signalosome subunit 5
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CSNK1D
|
casein kinase 1, delta
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CST3
|
cystatin C
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CUX1
|
cut-like homeobox 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYYR1
|
cysteine/tyrosine-rich 1
|
|
DAO
|
D-amino-acid oxidase
|
|
DCPS
|
decapping enzyme, scavenger
|
|
DDX17
|
DEAD (Asp-Glu-Ala-Asp) box helicase 17
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DEFB103B
|
defensin, beta 103B
|
|
DFFB
|
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)
|
|
DLAT
|
dihydrolipoamide S-acetyltransferase
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DMD
|
dystrophin
|
|
DOK7
|
docking protein 7
|
|
DRD4
|
dopamine receptor D4
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DSG1
|
desmoglein 1
|
|
DST
|
dystonin
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
EARS2
|
glutamyl-tRNA synthetase 2, mitochondrial
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EFNB2
|
ephrin-B2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
ELMO1
|
engulfment and cell motility 1
|
|
ELN
|
elastin
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPHA2
|
EPH receptor A2
|
|
EPHB2
|
EPH receptor B2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
F2
|
coagulation factor II (thrombin)
|
|
FANCC
|
Fanconi anemia, complementation group C
|
|
FAT4
|
FAT atypical cadherin 4
|
|
FBXO11
|
F-box protein 11
|
|
FBXO7
|
F-box protein 7
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FERMT3
|
fermitin family member 3
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FLCN
|
folliculin
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOXE3
|
forkhead box E3
|
|
FOXM1
|
forkhead box M1
|
|
FOXP3
|
forkhead box P3
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT6
|
fucosyltransferase 6 (alpha (1,3) fucosyltransferase)
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GALNS
|
galactosamine (N-acetyl)-6-sulfatase
|
|
GBA2
|
glucosidase, beta (bile acid) 2
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GFPT1
|
glutamine--fructose-6-phosphate transaminase 1
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GIPC3
|
GIPC PDZ domain containing family, member 3
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GM2AP1
|
GM2 ganglioside activator pseudogene 1
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GNRH2
|
gonadotropin-releasing hormone 2
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GUCY2D
|
guanylate cyclase 2D, membrane (retina-specific)
|
|
HBD
|
hemoglobin, delta
|
|
HFE
|
hemochromatosis
|
|
HFE2
|
hemochromatosis type 2 (juvenile)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNRNPC
|
heterogeneous nuclear ribonucleoprotein C (C1/C2)
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HOXB4
|
homeobox B4
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTT
|
huntingtin
|
|
HVCN1
|
hydrogen voltage gated channel 1
|
|
IAPP
|
islet amyloid polypeptide
|
|
IFI35
|
interferon-induced protein 35
|
|
IFN1@
|
interferon, type 1, cluster
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFALS
|
insulin-like growth factor binding protein, acid labile subunit
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL11
|
interleukin 11
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL23R
|
interleukin 23 receptor
|
|
IL6
|
interleukin 6
|
|
INPP5E
|
inositol polyphosphate-5-phosphatase, 72 kDa
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IRF7
|
interferon regulatory factor 7
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK2
|
Janus kinase 2
|
|
JUND
|
jun D proto-oncogene
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA2022
|
KIAA2022
|
|
KIF2C
|
kinesin family member 2C
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KLK14
|
kallikrein-related peptidase 14
|
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
KNG1
|
kininogen 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LAMB2
|
laminin, beta 2 (laminin S)
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LDLR
|
low density lipoprotein receptor
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LMNB1
|
lamin B1
|
|
LRTOMT
|
leucine rich transmembrane and O-methyltransferase domain containing
|
|
LTB4R
|
leukotriene B4 receptor
|
|
LY96
|
lymphocyte antigen 96
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK4
|
mitogen-activated protein kinase 4
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAPK5
|
mitogen-activated protein kinase-activated protein kinase 5
|
|
MARS
|
methionyl-tRNA synthetase
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MBNL1
|
muscleblind-like splicing regulator 1
|
|
MBP
|
myelin basic protein
|
|
MCCC1
|
methylcrotonoyl-CoA carboxylase 1 (alpha)
|
|
MCCC2
|
methylcrotonoyl-CoA carboxylase 2 (beta)
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED25
|
mediator complex subunit 25
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR181B1
|
microRNA 181b-1
|
|
MIR34C
|
microRNA 34c
|
|
MIR376C
|
microRNA 376c
|
|
MMAB
|
methylmalonic aciduria (cobalamin deficiency) cblB type
|
|
MSH2
|
mutS homolog 2
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MT-TL1
|
tRNA
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
NAA60
|
N(alpha)-acetyltransferase 60, NatF catalytic subunit
|
|
NANOG
|
Nanog homeobox
|
|
NBN
|
nibrin
|
|
NCK1
|
NCK adaptor protein 1
|
|
NEO1
|
neogenin 1
|
|
NEUROG1
|
neurogenin 1
|
|
NEUROG2
|
neurogenin 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NMI
|
N-myc (and STAT) interactor
|
|
NMU
|
neuromedin U
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOG
|
noggin
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NOTCH4
|
notch 4
|
|
NOV
|
nephroblastoma overexpressed
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NSF
|
N-ethylmaleimide-sensitive factor
|
|
NUBP1
|
nucleotide binding protein 1
|
|
NUMA1
|
nuclear mitotic apparatus protein 1
|
|
NUP35
|
nucleoporin 35kDa
|
|
OFD1
|
oral-facial-digital syndrome 1
|
|
OSM
|
oncostatin M
|
|
OTC
|
ornithine carbamoyltransferase
|
|
PAF1
|
Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae)
|
|
PAGR1
|
PAXIP1 associated glutamate-rich protein 1
|
|
PAX6
|
paired box 6
|
|
PDCD1
|
programmed cell death 1
|
|
PDE6D
|
phosphodiesterase 6D, cGMP-specific, rod, delta
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PF4
|
platelet factor 4
|
|
PGF
|
placental growth factor
|
|
PIH1D1
|
PIH1 domain containing 1
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLA2G4D
|
phospholipase A2, group IVD (cytosolic)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLK1
|
polo-like kinase 1
|
|
PML
|
promyelocytic leukemia
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POU3F4
|
POU class 3 homeobox 4
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKD2
|
protein kinase D2
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROM1
|
prominin 1
|
|
PSMB1
|
proteasome (prosome, macropain) subunit, beta type, 1
|
|
PSMD4
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASD2
|
RASD family, member 2
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1
|
|
RCAN1
|
regulator of calcineurin 1
|
|
RMND5A
|
required for meiotic nuclear division 5 homolog A (S. cerevisiae)
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RNF111
|
ring finger protein 111
|
|
RORC
|
RAR-related orphan receptor C
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RPGRIP1
|
retinitis pigmentosa GTPase regulator interacting protein 1
|
|
RPSA
|
ribosomal protein SA
|
|
RTN4R
|
reticulon 4 receptor
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RXRA
|
retinoid X receptor, alpha
|
|
SALL2
|
spalt-like transcription factor 2
|
|
SCG2
|
secretogranin II
|
|
SCG3
|
secretogranin III
|
|
SELK
|
selenoprotein K
|
|
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SETDB1
|
SET domain, bifurcated 1
|
|
SH2B1
|
SH2B adaptor protein 1
|
|
SHH
|
sonic hedgehog
|
|
SIRT3
|
sirtuin 3
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOST
|
sclerostin
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SP1
|
Sp1 transcription factor
|
|
SPTB
|
spectrin, beta, erythrocytic
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
SYT14
|
synaptotagmin XIV
|
|
TAZ
|
tafazzin
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
TGM6
|
transglutaminase 6
|
|
THBS1
|
thrombospondin 1
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TRRAP
|
transformation/transcription domain-associated protein
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSEN54
|
TSEN54 tRNA splicing endonuclease subunit
|
|
TTN
|
titin
|
|
TXNRD1
|
thioredoxin reductase 1
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UHRF1
|
ubiquitin-like with PHD and ring finger domains 1
|
|
UPK1A
|
uroplakin 1A
|
|
USH2A
|
Usher syndrome 2A (autosomal recessive, mild)
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VWF
|
von Willebrand factor
|
|
WDR5
|
WD repeat domain 5
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WT1
|
Wilms tumor 1
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
ZBTB33
|
zinc finger and BTB domain containing 33
|
|
ZIC1
|
Zic family member 1
|
|
ZIC4
|
Zic family member 4
|
